Nuvectis Pharma, Inc. (NVCT) — Stock Score Summary

Nuvectis Pharma, Inc. (NVCT) has a MoatMap StockRank of 20/100 based on Quality (21/100), Value (22/100), and Momentum (62/100) factor scores. The current signal is STRONG SELL. Nuvectis Pharma is an early-stage oncology drug developer with a low quality score of 21. It lacks commercialized products, pricing power, or the validated manufacturing scale that would allow it to benefit from the CDMO pricing power cycle.

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutic solutions for the treatment of cancer. The company focuses on advancing a pipeline of proprietary oncology drug candidates, aiming to address significant unmet needs in various tumor types through targeted approaches and novel mechanisms of action.

Key Financial Metrics

Price$9.31
Market Cap$270M
P/E (Forward)-10.07
Price/Book18.04
Return on Equity-154.4%
Return on Invested Capital-149.8%
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-9M

Nuvectis Pharma, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Nuvectis Pharma, Inc.’s (NVCT) StockRank?
MoatMap’s StockRank for Nuvectis Pharma, Inc. (NVCT) is 20/100, with a Strong Sell signal. It is a composite of Quality (21), Value (22), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Nuvectis Pharma, Inc. have an economic moat?
Nuvectis Pharma, Inc. (NVCT) has a Quality factor score of 21/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Nuvectis Pharma, Inc. a buy, hold, or sell?
MoatMap’s current signal for Nuvectis Pharma, Inc. (NVCT) is Strong Sell, based on a StockRank of 20/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Nuvectis Pharma, Inc. in?
Nuvectis Pharma, Inc. (NVCT) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksNVCT deep dive reportAI ChampionsHow we score stocksSense-check another stock